Author name: DrugPatentWatch

Pharmaceutical companies employ various strategies to extend the commercial life and patent protection of successful drugs. Here are some key […]

“Patents reward drugmakers for their inventions and, effectively, the large sums of money they invest in research and development. The

In the “Patent Effect” podcast, Mustafa introduces his guest, Hakan Yum, the IP Director of Exrain Pharma, based in Sweden.

In a recent study published in the Expert Review of Medical Devices, researchers investigated the utilization of patent term extensions

Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate

The pharmaceutical industry in China is undergoing a significant transformation with the adoption of artificial intelligence (AI) technology. A recent

A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to

A recent study published in JAMA Health Forum sheds light on the impact of biosimilar competition on patient out-of-pocket (OOP)

A recent article in Communications of the ACM explores opportunities for “Permissionless innovation” in pharmaceuticals. “Permissionless innovation” refers to the